Altered adhesion features and signal transduction in NRK-49F cells transformed by down-regulation of lysyl oxidase

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1647, Issue 1-2, 2003, Pages 239-244

  Giampuzzi, Monia ^a   Oleggini, Roberta ^a   Di Donato, Armando ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

C jun; Cell adhesion; Lysyl oxidase; ras activation; Tumor suppressor; Catenin

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE; PROTEIN LYSINE 6 OXIDASE; STRESS ACTIVATED PROTEIN KINASE; CATNB PROTEIN, RAT; CYCLIN D1; CYTOSKELETON PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; CELL ADHESION; CELL TRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOLECULAR DYNAMICS; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; CELL CULTURE; CYTOLOGY; FIBROBLAST; KIDNEY; METABOLISM; ONCOGENE RAS; PHYSIOLOGY;

ANIMALS; BETA CATENIN; CELL ADHESION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN D1; CYTOSKELETAL PROTEINS; DOWN-REGULATION; FIBROBLASTS; GENES, RAS; GLYCOGEN SYNTHASE KINASE 3; KIDNEY; PROTEIN-LYSINE 6-OXIDASE; RATS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 1242273595     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-9639(03)00058-X     Document Type: Conference Paper

References (30)

1. Li W., Liu G., Chou I.N., Kagan H.M. Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells. J. Cell. Biochem. 78:2000;550-557.
2. Dimaculangan D.D., Chawla A., Boak A., Kagan H.M., Lazar M.A. Retinoic acid prevents downregulation of ras recision gene/lysyl oxidase early in adipocyte differentiation. Differentiation. 58:1994;47-52.
3. Hajnal A., Klemenz R., Schäfer R. Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts. Cancer Res. 53:1993;4670-4675.
4. Kenyon K., Contente S., Trackman P.C., Tang J., Kagan H.M., Friedman R.M. Lysyl oxidase and rrg messenger RNA. Science. 253:1991;802.
5. Krzyzosiak W.J., Shindo-Okada N., Teshima H., Nakajima K., Nishimura S. Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine. Proc. Natl. Acad. Sci. U. S. A. 89:1992;4879-4883.
6. Di Donato A., Lacal J.C., Di Duca M., Giampuzzi M., Ghiggeri G., Gusmano R. Micro-injection of recombinant lysyl oxidase blocks oncogenic p21-Ha-Ras and progesterone effects on Xenopus laevis oocyte maturation. FEBS Lett. 419:1997;63-68.
7. Giampuzzi M., Botti G., Cilli M., Gusmano R., Borel A., Sommer P., Di Donato A. Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene. J. Biol. Chem. 276:2001;29226-29232.
8. Laemmli U.K. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature. 227:1970;680-685.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
10. Paasinen-Sohns A., Holtta E. Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression. Oncogene. 15:1997;1953-1966.
11. Mudher A., Chapman S., Richardson J., Asuni A., Gibb G., Pollard C., Killick R., Iqbal T., Raymond L., Varndell I., Sheppard P., Makoff A., Gower E., Soden P.E., Lewis P., Murphy M., Golde T.E., Rupniak H.T., Anderton B.H., Lovestone S. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. J. Neurosci. 21:2001;4987-4995.
12. Lacal J.C., Fleming T.P., Warren B.S., Blumberg P.M., Aaronson S.A. Involvement of functional protein kinase C in the mitogenic response to the H-ras oncogene product. Mol. Cell. Biol. 7:1987;4146-4149.
13. Lisovsky M., Itoh K., Sokol S.Y. Frizzled receptors activate a novel JNK-dependent pathway that may lead to apoptosis. Curr. Biol. 12:2002;53-58.
14. Chen R.H., Ding W.V., McCormick F. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. J. Biol. Chem. 275:2000;17894-17899.
15. Sutherland C., Leighton I.A., Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 296:1993;15-19.
16. Ding V.W., Chen R.H., McCormick F. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J. Biol. Chem. 275:2000;32475-32481.
17. Devereux T.R., Anna C.H., Foley J.F., White C.M., Sills R.C., Barrett J.C. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene. 18:1999;4726-4733.
18. Koesters R., Hans M.A., Benner A., Prosst R., Boehm J., Gahlen J., Doeberitz M.K. Predominant mutation of codon 41 of the beta-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. Carcinogenesis. 22:2001;1885-1890.
19. Koesters R., Ridder R., Kopp-Schneider A., Betts D., Adams V., Niggli F., Briner J., von Knebel Doeberitz M. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res. 59:1999;3880-3882.
20. Lickert H., Bauer A., Kemler R., Stappert J. Casein kinase II phosphorylation of E-cadherin increases E-cadherin/beta-catenin interaction and strengthens cell-cell adhesion. J. Biol. Chem. 275:2000;5090-5095.
21. Morin P.J. Beta-catenin signaling and cancer. BioEssays. 21:1999;1021-1030.
22. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U. S. A. 96:1999;5522-5527.
23. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426.
24. Behrens J. Control of beta-catenin signaling in tumor development. Ann. N.Y. Acad. Sci. 910:2000;21-33. (discussion 33-5).
25. Iwao K., Miyoshi Y., Nawa G., Yoshikawa H., Ochi T., Nakamura Y. Frequent beta-catenin abnormalities in bone and soft-tissue tumors. Jpn. J. Cancer Res. 90:1999;205-209.
26. Michaelson J.S., Leder P. Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene. 20:2001;5093-5099.
27. Miyoshi Y., Iwao K., Nagasawa Y., Aihara T., Sasaki Y., Imaoka S., Murata M., Shimano T., Nakamura Y. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res. 58:1998;2524-2527.
28. Miyoshi Y., Iwao K., Nawa G., Yoshikawa H., Ochi T., Nakamura Y. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol. Res. 10:1998;591-594.
29. Nellaiappan K., Risitano A., Liu G., Nicklas G., Kagan H.M. Fully processed lysyl oxidase catalyst translocates from the extracellular space into nuclei of aortic smooth-muscle cells. J. Cell. Biochem. 79:2000;576-582.
30. Giampuzzi M., Botti G., Di Duca M., Arata L., Ghiggeri G., Gusmano R., Ravazzolo R., Di Donato A. Lysyl oxidase activates the transcription activity of human collagene III promoter. Possible involvement of Ku antigen. J. Biol. Chem. 275:2000;36341-36349.